Psoriasis

Psoriasis & Eczema Workshop

Date: 24th September 2019

Cost: Free

London

Empowering clinical pharmacists to manage psoriasis & eczema effectively and improve outcomes for patients

Our interactive workshops will combine expert speakers and sharing of best practice by our clinical pharmacist facilitators who are conducting psoriasis & eczema services in their own practices.

The i2i Network has been comissioned by LEO Pharma to deliver these workshops which have been entirely initiated and funded by LEO Pharma.

 

Speakers

Ruari O’Connell

Ruari is a senior GP pharmacist IP in Bristol who has experience in running dermatology clinics in his practice and effectively managing patients with psoriasis and eczema in his clinics.

Read Bio
Dr Faisal Ali

Dr Faisal Ali is one of the lead Consultant Dermatologists in the award-winning Vernova Healthcare Community Interest Company, a social enterprise in East Cheshire (BMJ Awards Dermatology Team of 2018) and Dermatological Surgeon in St John’s Institute of Dermatology, London.

Read Bio

Agenda

The workshop will focus on ‘insight’ in the morning and on ‘implementation’ in the afternoon. The day has been structured to allow plenty of networking time and activities.

Supported by

sponsor

These meetings have been commissioned and funded by LEO Pharma.  LEO Pharma suggested the speakers, commented on the speaker briefs and attended the faculty meeting when the content for the workshops were discussed for development. The agenda was developed by Soar Beyond in conjunction with LEO Pharma. Soar Beyond has paid the speaker honoraria on behalf of LEO Pharma.  The content has been reviewed for technical accuracy and  checked to ensure its compliance with appropriate regulations and legislation by LEO Pharma.

 

UKMAT-26779

Date of preparation July 2019

This workshop is no longer available.

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.